113 related articles for article (PubMed ID: 14523533)
1. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of immunohistochemical studies].
Montenarh M
HNO; 2003 Oct; 51(10):787-9. PubMed ID: 14523530
[No Abstract] [Full Text] [Related]
4. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
Bockmühl U; Küchler I; Petersen I
HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
[TBL] [Abstract][Full Text] [Related]
5. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
[TBL] [Abstract][Full Text] [Related]
7. [Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].
Koscielny S
Laryngorhinootologie; 2003 Mar; 82(3):197-8. PubMed ID: 12673521
[No Abstract] [Full Text] [Related]
8. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in head-neck carcinomas].
Weber A; Tannapfel A
HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
12. [Polarographic detection of reoxygenation of lymph node metastases in the initial phase of primary radio- and radiochemotherapy in patients with advanced squamous epithelial carcinomas of the head and neck].
Vanselow B; Dietz A; Rudat V; Wollensack P; Bettscheider C; Eble MJ
HNO; 1997 Mar; 45(3):140-6. PubMed ID: 9417437
[TBL] [Abstract][Full Text] [Related]
13. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
Bosch FX; Homann N; Conradt C; Dietz A; Erber R
HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
[No Abstract] [Full Text] [Related]
14. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
15. [Deletion of chromosome 10q--a marker for metastasis of head-neck carcinomas?].
Bockmühl U; Schmidt S; Petersen S; Petersen I
Laryngorhinootologie; 2000 Feb; 79(2):81-5. PubMed ID: 10738714
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
[TBL] [Abstract][Full Text] [Related]
17. Unresectable primary and recurrent head and neck tumors: effect of hyperthermia and carboplatin--preliminary experience.
Chang P; Sapozink MD; Grunberg SM; Jozsef G; Rice DM; Formenti SC; Streeter OE
Radiology; 2000 Mar; 214(3):688-92. PubMed ID: 10715031
[TBL] [Abstract][Full Text] [Related]
18. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
19. [Translational research in head and neck cancer. Biological characteristics and general aspects].
Dietz A; Wichmann G
HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
[TBL] [Abstract][Full Text] [Related]
20. [Capsular rupture of lymph node metastases as most significant prognostic factor in head and neck squamous cell carcinomas--Hamburg experiences].
Wenzel S; Sagowski C; Kehrl W; Aksima T; Metternich FU
Laryngorhinootologie; 2003 Oct; 82(10):707-12. PubMed ID: 14593569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
